Clinical Trial to Reduce Perinatal Intimate Partner Violence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Pittsburgh
About this trial
This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors
Eligibility criteria
Qualifiers
1) feel comfortable completing the study in Spanish or English
2) are age 18 or older
3) are no more than 24 weeks 6 days gestation (note: participants enrolled earliest at 18 weeks, baseline at 22 weeks with a 3 week window)
4) identify as an IPV survivor by answering affirmatively to a definition of experiencing IPV
Disqualifiers
Unable to consent
Do not meet inclusion criteria
Cannot provide safe contact information or take a study cell phone
Incarcerated
Trial design
Treatments tested in this trial
- Doulas
- Thrive
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Pittsburgh
Lead sponsor
National Institute of Nursing Research (NINR)
Collaborator
Source ClinicalTrials.gov